Literature DB >> 3121846

Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit.

V Gisclard1, V M Miller, P M Vanhoutte.   

Abstract

Experiments were designed to determine the effect of 17 beta-estradiol on endothelium-dependent responses of isolated arteries. Ovariectomized female New Zealand rabbits were treated either with 17 beta-estradiol (100 micrograms i.m.) or with solvent for 4 days. After excision, femoral arteries were cut into rings and suspended for isometric tension recording in organ chambers filled with modified Krebs-Ringer bicarbonate solution. Rings from the 17 beta-estradiol-treated rabbits showed an enhanced endothelium-dependent relaxation to acetylcholine (3 x 10(-9)-3 x 10(-8) M) in the absence or presence of indomethacin. Under the same experimental conditions, the endothelium-dependent responses to the calcium ionophore A23187 were unchanged. In the absence of indomethacin, the response to adenosine diphosphate was depressed in rings with endothelium taken from animals treated with with 17 beta-estradiol; in the presence of the inhibitor of cyclooxygenase, the endothelium-dependent responses were comparable in blood vessels from treated and untreated rabbits. This study suggests that endothelium-dependent responses of arteries can be modulated by steroid hormones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121846

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

1.  Do sex and hormonal status influence choroidal circulation?

Authors:  M Centofanti; S Bonini; G Manni; C Guinetti-Neuschüler; M G Bucci; A Harris
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

Review 2.  St Cyres lecture. Endothelium in control.

Authors:  A H Henderson
Journal:  Br Heart J       Date:  1991-03

3.  Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study.

Authors:  Hamza Duygu; Levent Akman; Filiz Ozerkan; Fuat Akercan; Mehdi Zoghi; Sanem Nalbantgil; Umit Erturk; Azem Akilli; Remzi Onder; Mustafa Akin
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-05       Impact factor: 2.357

4.  Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation.

Authors:  C R Rosenfeld; B E Cox; T Roy; R R Magness
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Role of estrogen receptor subtypes in estrogen-induced organ-specific vasorelaxation after trauma-hemorrhage.

Authors:  Zheng F Ba; Irshad H Chaudry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-19       Impact factor: 4.733

6.  Induction of calcium-dependent nitric oxide synthases by sex hormones.

Authors:  C P Weiner; I Lizasoain; S A Baylis; R G Knowles; I G Charles; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production.

Authors:  Xiaoyuan Han; Rui Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2013-11-06       Impact factor: 4.432

8.  Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.

Authors:  Virginia M Miller
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

9.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.